No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs11379141 |
chr3:52930477-52930478 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs563195922 |
chr3:52930483-52930484 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs530806949 |
chr3:52930484-52930485 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs398038706 |
chr3:52930486-52930487 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs375234625 |
chr3:52930508-52930509 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs189169065 |
chr3:52930591-52930592 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs181007099 |
chr3:52930662-52930663 |
Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs546786040 |
chr3:52930700-52930701 |
Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs566579221 |
chr3:52930762-52930763 |
Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs139924336 |
chr3:52930782-52930783 |
Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs149827784 |
chr3:52930803-52930804 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs370803731 |
chr3:52930830-52930831 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs183940691 |
chr3:52930846-52930847 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs188668777 |
chr3:52930906-52930907 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs558405370 |
chr3:52930973-52930974 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs181258667 |
chr3:52931007-52931008 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs545745026 |
chr3:52931012-52931013 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs368476636 |
chr3:52931079-52931080 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs541636023 |
chr3:52931106-52931107 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs559228112 |
chr3:52931143-52931144 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs572964196 |
chr3:52931207-52931208 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs561841346 |
chr3:52931219-52931220 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs553148193 |
chr3:52931233-52931234 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs530694654 |
chr3:52931275-52931276 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs550616631 |
chr3:52931289-52931290 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs376857317 |
chr3:52931294-52931295 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs200458743 |
chr3:52931299-52931300 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs372649372 |
chr3:52931300-52931301 |
Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs533174899 |
chr3:52931443-52931444 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs111561856 |
chr3:52931456-52931457 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs546971111 |
chr3:52931494-52931495 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs113908723 |
chr3:52931543-52931544 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs566666536 |
chr3:52931570-52931571 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs535539150 |
chr3:52931582-52931583 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs549193739 |
chr3:52931613-52931614 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs569132894 |
chr3:52931682-52931683 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs559777814 |
chr3:52931688-52931689 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs377110320 |
chr3:52931709-52931710 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs185720229 |
chr3:52931758-52931759 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs533697037 |
chr3:52931778-52931779 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs538403040 |
chr3:52931820-52931821 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs558179390 |
chr3:52931843-52931844 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG islandlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs190268321 |
chr3:52931896-52931897 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs377345855 |
chr3:52931946-52931947 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs539100361 |
chr3:52931954-52931955 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs570122935 |
chr3:52931958-52931959 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs552987325 |
chr3:52931962-52931963 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs9844736 |
chr3:52931971-52931972 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
49 |
rs541966391 |
chr3:52932033-52932034 |
Enhancers Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs561731548 |
chr3:52932034-52932035 |
Enhancers Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|